BioCentury | Dec 13, 2010
Clinical News

ProAdeno+ assay regulatory update

...FDA granted 510(k) clearance for the ProAdeno+ assay from Gen-Probe's Prodesse Inc. subsidiary as an aid in...
BioCentury | Aug 2, 2010
Clinical News

ProFast+ assay regulatory update

...FDA granted 510(k) clearance for the ProFast+ assay from Gen-Probe's Prodesse Inc. subsidiary to detect and differentiate...
BioCentury | Dec 7, 2009
Clinical News

ProParaflu+ regulatory update

...FDA granted 510(k) clearance for the ProParaflu+ assay from Gen-Probe's Prodesse Inc. subsidiary for use to detect...
BioCentury | Nov 2, 2009
Company News

Gen-Probe, Prodesse deal

...Gen-Probe completed its previously announced acquisition of molecular diagnostic company Prodesse for $60 million in cash...
...$25 million in potential milestones (see BioCentury, Oct. 12). Gen-Probe Inc. (NASDAQ:GPRO), San Diego, Calif. Prodesse Inc....
BioCentury | Nov 2, 2009
Finance

Ebb & Flow

...was off $1.09 to $41.72 last week after FDA granted an emergency use authorization for Prodesse...
BioCentury | Nov 2, 2009
Clinical News

Prodesse ProFlu-ST regulatory update

...FDA granted an emergency use authorization (EUA) for Gen-Probe's Prodesse ProFlu-ST to diagnose swine influenza A...
...test through its acquisition of Prodesse Inc. last month. Gen-Probe Inc. (NASDAQ:GPRO), San Diego, Calif. Product: Prodesse...
BioCentury | Oct 30, 2009
Company News

FDA grants emergency use for Gen-Probe's H1N1 diagnostic

...FDA granted an emergency use authorization (EUA) for Prodesse ProFlu-ST from Gen-Probe Inc. (NASDAQ:GPRO) to diagnose...
...set to expire on April 26, 2010. Gen-Probe gained the test through its acquisition of Prodesse Inc....
BioCentury | Oct 12, 2009
Company News

Gen-Probe, Prodesse deal

...Gen-Probe will acquire molecular diagnostic company Prodesse for $60 million in cash on hand, plus up...
...for $60 million in cash on hand, plus up to $25 million in potential milestones. Prodesse...
...month. XMS Capital Partners and Leerink Swann advised Prodesse. Gen-Probe Inc. (NASDAQ:GPRO), San Diego, Calif. Prodesse Inc....
BioCentury | Jan 28, 2008
Clinical News

ProFlu+ regulatory update

...FDA granted 510(k) clearance to Prodesse for the ProFlu+ assay to detect influenza A virus, influenza...
...from a patient's respiratory secretions. The company said the test has been made commercially available. Prodesse Inc....
BioCentury | Jul 31, 2006
Company News

Invitrogen, Prodesse deal

...IVGN granted Prodesse a nonexclusive worldwide license to use its LUX (light upon extension) technology to...
...eligible for milestones and royalties. Further terms were not disclosed. Invitrogen Corp. (IVGN), Carlsbad, Calif. Prodesse Inc....
Items per page:
1 - 10 of 13
BioCentury | Dec 13, 2010
Clinical News

ProAdeno+ assay regulatory update

...FDA granted 510(k) clearance for the ProAdeno+ assay from Gen-Probe's Prodesse Inc. subsidiary as an aid in...
BioCentury | Aug 2, 2010
Clinical News

ProFast+ assay regulatory update

...FDA granted 510(k) clearance for the ProFast+ assay from Gen-Probe's Prodesse Inc. subsidiary to detect and differentiate...
BioCentury | Dec 7, 2009
Clinical News

ProParaflu+ regulatory update

...FDA granted 510(k) clearance for the ProParaflu+ assay from Gen-Probe's Prodesse Inc. subsidiary for use to detect...
BioCentury | Nov 2, 2009
Company News

Gen-Probe, Prodesse deal

...Gen-Probe completed its previously announced acquisition of molecular diagnostic company Prodesse for $60 million in cash...
...$25 million in potential milestones (see BioCentury, Oct. 12). Gen-Probe Inc. (NASDAQ:GPRO), San Diego, Calif. Prodesse Inc....
BioCentury | Nov 2, 2009
Finance

Ebb & Flow

...was off $1.09 to $41.72 last week after FDA granted an emergency use authorization for Prodesse...
BioCentury | Nov 2, 2009
Clinical News

Prodesse ProFlu-ST regulatory update

...FDA granted an emergency use authorization (EUA) for Gen-Probe's Prodesse ProFlu-ST to diagnose swine influenza A...
...test through its acquisition of Prodesse Inc. last month. Gen-Probe Inc. (NASDAQ:GPRO), San Diego, Calif. Product: Prodesse...
BioCentury | Oct 30, 2009
Company News

FDA grants emergency use for Gen-Probe's H1N1 diagnostic

...FDA granted an emergency use authorization (EUA) for Prodesse ProFlu-ST from Gen-Probe Inc. (NASDAQ:GPRO) to diagnose...
...set to expire on April 26, 2010. Gen-Probe gained the test through its acquisition of Prodesse Inc....
BioCentury | Oct 12, 2009
Company News

Gen-Probe, Prodesse deal

...Gen-Probe will acquire molecular diagnostic company Prodesse for $60 million in cash on hand, plus up...
...for $60 million in cash on hand, plus up to $25 million in potential milestones. Prodesse...
...month. XMS Capital Partners and Leerink Swann advised Prodesse. Gen-Probe Inc. (NASDAQ:GPRO), San Diego, Calif. Prodesse Inc....
BioCentury | Jan 28, 2008
Clinical News

ProFlu+ regulatory update

...FDA granted 510(k) clearance to Prodesse for the ProFlu+ assay to detect influenza A virus, influenza...
...from a patient's respiratory secretions. The company said the test has been made commercially available. Prodesse Inc....
BioCentury | Jul 31, 2006
Company News

Invitrogen, Prodesse deal

...IVGN granted Prodesse a nonexclusive worldwide license to use its LUX (light upon extension) technology to...
...eligible for milestones and royalties. Further terms were not disclosed. Invitrogen Corp. (IVGN), Carlsbad, Calif. Prodesse Inc....
Items per page:
1 - 10 of 13